Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ISR Holdings AB, enters important collaboration regarding Hepatitis B with Beijing Kawin Technology Share-Holding Co., Ltd.

The board of ISR Immune System Regulation Holding AB (ISR) has signed a Memorandum of Understanding, with Beijing Kawin Technology Share-Holding Co., Ltd. (KAWIN), in order to develop ISRs immunolide ISR50 for Hepatitis B (HBV). ISR50 is a TLR agonist for an immunostimulatory treatment of HBV, a compound with a mode of action based on 2011 Nobel prize.Together with KAWIN, ISR will initiate pre-clinical testing in animal models of HBV evaluating the immunostimulatory properties of ISR50. KAWIN has received a Right of First Refusal (ROFR), which stipulates that KAWIN has the license for the

Changes in Veidekke's corporate management

Veidekke ASA is making changes in the group’s management team, effective 15 September 2020. The purpose is to ensure renewal, broaden the experience base of the management team, and bolster the group structure.The divestment of the property development operation and the establishment of Veidekke Infrastructure have altered the group’s structure, and Veidekke is now a streamlined contractor. “Over the past year, Veidekke has made important changes to the group structure, and is now a streamlined contractor. The changes in the group management team will make Veidekke a stronger

Mentice receives order of total SEK 5.5 million from BD (former Bard Peripheral Vascular)

Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, receives order from BD (former Bard Peripheral Vascular) for the segment Medical Device Industry relating to solutions for physician training in the peripheral vascular area. The order covers system sales for a total order value of SEK 5.5 million and will be delivered during the third quarter 2020. Mentice receives order from BD (APAC) relating to systems providing training solutions to support multiple BD franchises in Asia Pacific to roll out

Orexo and GoGoMeds Partner to Bring Digital Therapies to Populations Battling Addiction and Depression with Limited Support Options

Alcohol and opioid misuse, and depression on the rise because of COVID-19 prompts response to address urgent needMorristown, New Jersey, September 9, 2020 – Orexo and GoGoMeds have formed a partnership to make the scientifically-proven, digital therapies deprexis® and vorvida® available for the treatment of depression and management of problematic alcohol misuse respectively. OXD01, a digital therapy for the treatment of opioid use disorders, will also be available in the US in Q4 2020 through the partnership. In April of this year, the FDA released an enforcement policy for digital

Getinge and partners showcase connectivity solutions for the quiet ICU of the future

Together with leading industry partners, Getinge is showcasing innovative connectivity solutions for creating a more quiet and healing environment for the intensive care unit (ICU). By distributing audible alarms outside patient rooms, ICUs will become calmer for patients, family members and provide caregivers a more efficient way of addressing alarms. The modern ICU uses a large number of medical devices that generate independent alarms. Without coordination, this can result in a cacophony of alarms causing unnecessary anxiety for patients and their families. “Our aim is to

Alligator Bioscience presents an update regarding the Phase I study with the drug candidate ATOR-1015

Lund, Sweden, September 9, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX) announced today updated timelines indicating 3-6 months delay for the planned Phase Ib study with ATOR-1015, its tumor-localizing, bispecific CTLA-4 and OX40 antibody developed for treatment of metastatic cancer. As previously communicated, preliminary data from the ongoing Phase I study have shown that ATOR-1015 is well tolerated at doses up to 600 mg (about 10 mg/kg), which is believed to be a clinically relevant dose range. At the current dose of 750 mg (~12.5 mg/kg), some grade 3 infusion related

Calmark signs distributor agreement in Jordan

Calmark Sweden AB has today signed an exclusive distributor agreement with the company Alpha Tech Est. in Amman, Jordan.Alpha Tech Est. is a distributor of medical equipment to maternity clinics, hospitals and health centers and thus already has customer contacts established in Calmark’s target group.  The distributor agreement grants Alpha Tech exclusive rights to sell and market the Calmark Neo platform in Jordan. Calmark's reader will initially be installed at two units in the market in order to obtain clinical data in view of the registration process. The next step is to register the

Faron to Present at H.C. Wainwright Conference

Faron Pharmaceuticals Ltd (“Faron” or the “Company”)Faron Pharmaceuticals to Present at the Virtual H.C. Wainwright 22[nd] Annual Global Investment Conference TURKU – FINLAND, September 9, 2020 – Faron Pharmaceuticals Ltd (“Faron”) (LON: FARN), the clinical stage biopharmaceutical company, today announced that Dr. Markku Jalkanen, Chief Executive Officer of Faron Pharmaceuticals, will present at the virtual H.C. Wainwright 22[nd] Annual Global Investment Conference on Wednesday, September 16, 2020 at 11:00 a.m. ET. To access a live webcast and subsequent archived recording of the

EPRA awarded Kojamo’s Financial Statements and Sustainability Report

Kojamo Plc Press Release, 9 September 2020 at 2:00 p.m. EESTEPRA awarded Kojamo’s Financial Statements and Sustainability Report European Public Real Estate Association (EPRA) has awarded Kojamo’s Financial Statements for 2019 a gold award for the second consecutive year and Kojamo’s Sustainability report for 2019 a silver award. Additionally, Kojamo received Most Improved award for developing its sustainability reporting. Kojamo’s Sustainability Report on the year 2019 marked the first time the company has applied the EPRA Sustainability Best Practices Recommendations. EPRA

Assemblin Ventilation acquires Luftkompaniet

Assemblin is acquiring Luftkompaniet Sjöblom AB (“Luftkompaniet”), a ventilation company with annual sales of approximately SEK 80 million and around 15 employees. Luftkompaniet operates primarily in the Stockholm region.Luftkompaniet has enjoyed continuous growth and healthy profitability since its founding in 1990. The company has a strong client portfolio and offers different types of works contracts, but also provides certain service operations. A strong culture with committed employees and lengthy, close customer relationships is what distinguishes the company. “Luftkompaniet is a

Agenda for Episurf Medical’s Digital Capital Markets Day 2020

Episurf Medical AB (Nasdaq: EPIS B) invites investors, analysts and media to the Group’s Digital Capital Markets Day on Tuesday September 15, 2020 at 13:00 CEST – 16:00 CEST. The purpose of the Capital Markets Day is to increase the understanding of Episurf Medical’s business, technology, clinical results and future opportunities.  Agenda Section 1, 13:00 CESTIntroduction, strategy and future opportunities, Pål Ryfors, CEOCorporate, Veronica Wallin, CFORegulatory and IP, Katarina Flodström, COO Section 2, approximately 13:50 CESTCartilage surgery: History and treatment

Lindab SolarRoof wins Energy Prize from Danish Building Centres

Lindab's newly developed SolarRoof(TM) is a complete roof system with integrated solar cells. SolarRoof has been awarded the Danish Building Centres’ Energy Prize 2020 with the motivation that Lindab has combined an established technology for steel roofs with the latest technology in solar energy.“Lindab SolarRoof is a good example of how we are constantly developing our products to meet new requirements. We are very proud that our work has been awarded by the Danish Building Centres. Solar panels on roofs are nothing new, but we wanted to make a solution that was easier to install with a

Progress for Keliber’s EIA program for Päiväneva lithium mine and concentrator

Keliber has received feedback from the Finnish authorities that the proposed EIA program (“Environmental Impact Assessment”) for the Päiväneva lithium mine and concentrator program meets the content requirements set for the EIA program in EIA legislation. Keliber’s press release is available at: https://www.keliber.fi/en/news/news-releases-and-publications/63CF5382F32D566D/. Oslo, 9 September 2020Nordic Mining ASANordic Mining ASA (www.nordicmining.com) Nordic Mining ASA ("Nordic Mining" or the "Company") is a resource company with focus on high-end industrial minerals and

poLight ASA – signed MoU and received purchase order to make a prototype of a new version of TLens

Horten, 9 September 2020 - poLight ASA (OSE: PLT) today announced that the company has signed an Memorandum of Understanding (MoU) and received a purchase order to develop a prototype of a new version of the TLens from an unnamed camera module supplier. Depending on the result of the prototype and the party’s strategic consideration, the aim is to release a new version of the TLens having a bigger aperture and hence fitting bigger sensor formats and new applications, primarily for the smartphone market.   The purchase order is worth NOK 1,3 million. “This represent a unique

Asetek Receives Order for New HPC Installation from Existing Data Center OEM Partner

Aalborg, Denmark, 9 September, 2020 - Asetek today announced it has received a new order from an existing HPC OEM partner for a new high-density cluster, for an undisclosed end customer and location.The order value is approximately USD 475,000 depending on final configuration, with delivery expected to be completed in Q4 2020.   About AsetekAsetek, the creator of the all-in-one liquid cooler, is the global leader for liquid cooling solutions for high performance gaming and enthusiast PCs, and environmentally aware data centers. Founded in 2000, Asetek is headquartered in Denmark and

The world’s first placebo-controlled clinical trial proves the successful application of cold plasma jet kINPen MED in diabetic foot ulcers: Reactivation and acceleration of wound healing confirmed

Chronic wounds resulting from diabetic foot syndrome heal significantly faster if the standard therapy is complemented with atmospheric cold plasma treatments. This has now been successfully proved by scientists in the first placebo-controlled, randomised and patient-blinded clinical trial. The study device used was the kINPen[®] MED plasmajet of neoplas med, a joint development with the Leibniz Institute for Plasma Science and Technology e. V. (INP). The study results have now been published in the Journal of the American Medical Association (JAMA Network Open).[1][ ]Diabetic foot ulcers (

Carbiotix first European AXOS patent is officially granted

Carbiotix (publ) ("Carbiotix") announces today that the company has received confirmation from the European Patent Office (EPO) that the company’s first AXOS patent has been officially granted. This is an important milestone in securing Carbiotix competitive position as the company accelerates AXOS scale-up activities on the market for prebiotic ingredients, and targets medical food and therapeutic applications.Carbiotix received confirmation from EPO that the company’s European Patent Application no. 16786855.3, titled: Preparation comprising Arabinoxylo-Oligosaccharides, has been

Finnair cuts flights for October – maintains critical connections for Finland

Finnair has updated its traffic programme for October. The demand for air travel in Finnair’s network has recovered slowly due to the development of the corona pandemic and related travel restrictions, and hence the previously published traffic programme cannot be implemented in full due to low demand. Finnair reduces flights from its traffic programme and flies approximately 70–80 daily flights instead of the previously planned approximately two hundred flights.   Flights are available at Finnair’s booking site finnair.com and in travel agencies’ booking systems.  Finnair

Invitation to attend Extraordinary General Meeting concerning reintroducing dividend for 2019

The shareholders of Kungsleden AB (publ) are hereby invited to attend the Extraordinary General Meeting, to be held on Monday 12 October 2020. Due to the Covid-19 pandemic, the Meeting will be carried out only through advance voting pursuant to temporary legislation. It will not be possible to attend the Meeting in person or by proxy.Preconditions for participation Shareholders who wish to, through advance voting, participate in the Extraordinary General Meeting shall     be registered in the shareholders’ register maintained by Euroclear Sweden AB on 2 October 2020, and shall

Visma continues its strategic expansion in the Dutch accountancy cloud with the acquisition of Cash Software

Visma , European leader in cloud business solutions, acquires online business software specialist Cash Software . With this strategic acquisition, which follows the acquisitions of Visionplanner, Nmbrs, and recently Yuki, the Visma Group continues to grow steadily in the Dutch accountancy and ERP market. Cash Software, of which Microloon has been a part for seven years, was founded in 1984 and has been developing business software for SMEs for over 35 years. More than 10,000 companies now work with CASH and Microloon, which together carry out

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

Announcement no. 39 - 9 September 2020 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, Motortramp A/S continuously sells shares pro rata and the market is to be informed accordingly – see the attached file. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451Anne-Louise Dam-Rasmussen, Head of Communications, tel.: +45 3273 0624

Nustay enters new partnership agreement with Bedsopia

Nustay A/S (“Nustay”) has today announced a new distribution agreement with Bedsopia. Bedsopia is a growing hotel supplier, offering direct access to 2,500 hotels across more than 25 countries.New Partnership Nustay has entered into a new distribution agreement with Bedsopia. Founded in 2016, Bedsopia provides Nustay with direct access to 2,500 hotels across more than 25 countries. Bedsopia offers competitive rates on highly rated properties by using an advanced and efficient API interface to provide its wide distribution base. The company’s multi-solution system can handle approximately

Sweden Offers Gripen to Croatia

Today, Sweden submitted its proposal of 12 new Gripen C/D fighter aircraft to Croatia.Representatives of the Swedish Defence Material Administration (FMV) and the Swedish Embassy in Croatia submitted the government-to-government proposal of 12 new Gripen C/D fighter aircraft to the Croatian authorities. Parallel to Sweden’s proposal, Saab is offering a tailored made strategic cooperation package that will boost the Croatian defence industry, and benefit Croatian security by building a long-term partnership with strategic sectors.  “Sweden and Saab are offering a comprehensive and long-

Nel ASA: Approval and publication of Prospectus

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. (Oslo, 9 September 2020) Reference is made to the stock exchange announcements by Nel ASA ("Nel" or the "Company") on 15 June 2020, regarding information relating to a subsequent offering of up to 10,840,109 new shares (the "Subsequent Offering") in the Company following the completion of a private placement with gross proceeds of NOK 1,300 million (the "

There are no items matching the current filter
There are no more items matching the current filter
Back to top